When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma.
The Director of KOL Management & Engagement will support Attruby (acoramidis) in ATTR-cardiomyopathy. The individual will have a deep understanding and relationships within the ATTR-CM community. They will drive cross-functional collaboration and tactical alignment, ensuring success in the US and across the globe. Additionally, this individual will lead the development of assessment, strategic and tactical development, and engagement with key opinion leaders. Success will be measured by gaining and sharing key insights, developing knowledge related to an asset and/or disease state, and developing mutually beneficial partnerships with relevant stakeholders.
This person will play a lead strategic role on the commercial product team and work closely with Market Insights, Development, Sales, Compliance, Regulatory, Medical Affairs, and other key stakeholders. The position requires excellent communication skills, leadership, and a proven ability to influence the organization. Candidates should feel at home in a fast-paced environment. This role will report to the Senior Director of HCP Marketing.
This is a field-based role in the Northwast U.S region.
We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
Financial Benefits:
Health & Wellbeing:
Skill Development & Career Paths:
BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 20+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs. Our focus on scientific excellence and rapid execution aim to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe. To learn more about our story and company culture, visit us at https://bridgebio.com
Please mention you found this job on AI Jobs. It helps us get more startups to hire on our site. Thanks and good luck!
Be the first to apply. Receive an email whenever similar jobs are posted.
Understand the required skills and qualifications, anticipate the questions you may be asked, and study well-prepared answers using our sample responses.
Director Q&A's